Skip to main content
. 2017 Nov-Dec;43(6):1043–1051. doi: 10.1590/S1677-5538.IBJU.2016.0627

Table 2. Pathologic data.

RRP (n=99) RALP (n=223) p value
Pathologic stage 0.634
T2 61(61.6) 129 (57.8)
T3a 26 (26.3) 65 (29.1)
T3b 12 (12.1) 26 (26.3)
T4 0 (0) 3 (1.3)
Pathologic Gleason score 0.744
6 33 (33.3) 86 (38.6)
7 37 (37.4) 80 (35.9)
8 24 (24.2) 42 (18.8)
9 4 (4.0) 13 (5.8)
10 1 (1.0) 2 (1.0)
Positive surgical margin (%) 30/99 (30.3) 83/223 (37.2) 0.230
Focal/extensive 13/17 35/48 0.484
Biochemical recurrence (%) 7 (3.2) 2 (2.0) 0.574

Mean follow up duration: 31.4±10.3 months